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Summary 
Various diverse extracellular proteins possess Ca2+- 
binding epidermal growth factor (EGF)-like domains, 
the function of which remains uncertain. We have de- 
termined, at high resolution (1.5 A), the crystal struc- 
ture of such a domain, from human clotting factor IX, 
as a complex with Ca2+, The Ca2+ ligands form a clas- 
sic pentagonal bipyramid with six ligands contributed 
by one polypeptlde chain and the seventh supplied by 
a neighboring EGF-like domain. The crystal structure 
identifies the role of Ca2+ in maintalning the conforma- 
tion of the N-terminal region of the domain, but more 
importantly demonstrates that Ca2+ can directly medi- 
ate protein-protein contacts. The observed crystal 
packing of the domains provides a plausible model for 
the association of multiple tandemly linked EGF-llke 
domains in proteins such as flbrillin-1, Notch, and pro- 
tein S. This model is consistent with the known func- 
tional data and suggests a general biological role for 
these domains. l 
Introduction 
A large number of extracellular proteins with diverse funC- 
tions, including those associated with blood coagulation 
and fibrinolysis, activation of complement, cell adhesion, 
and developmental determination of embryonic cell fates, 
contain epidermal growth factor (EGF)-like domains (for 
reviews see Stenflo, 1991; Campbell and Bork, 1993). This 
cysteine-rich domain, first described in EGF itself (Savage 
et al., 1972), contains - 40-50 amino acid residues includ- 
ing six conserved cysteine residues that form three disul- 
phide bonds. The domain may exist as a single copy or 
as multiple copies within proteins and in association with 
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other different protein modules (Campbell and Bork, 
1993). Because of its widespread distribution among ex- 
tracellular proteins, there has been considerable interest 
in the biological role of the EGF-like domain, which is pre- 
sumed to be involved in mediating protein-protein interac- 
tions (Campbell and Bork, 1993). 
A subset of EGF-like domains contain five amino acids 
that constitute a Ca--binding consensus sequence: Asp/ 
Asn, Asp/Asn, GlnlGlu, Asp*/Asn*, Tyr/Phe, in which the 
asterisk may be a fi-hydroxylated residue (Rees et al., 
1988; Handford et al., 1991). Ca2+ binding to this type of 
domain was first demonstrated in the vitamin K-depen- 
dent plasma proteins: factors IX and X, protein C, and 
protein S (Ohlin et al., 1988; Huang et al., 1989; Persson 
et al., 1989; Handford et al., 1990; Dahlback et al., 1990). 
Subsequently, Ca% was shown to bind to EGF-like do- 
mains from the connective tissue protein fibrillin-1 (Glan- 
ville et al., 1994; Handford et al., 1995). The importance 
of each of the consensus residues for ligand binding was 
established by extensive mutagenic studies on the Ca2+- 
binding EGF-like domain from human clotting factor IX 
(Handford et al., 1991; Mayhew et al., 1992; Hughes et 
al., 1993). 
The functional importance of Ca*+ binding was demon- 
strated by the identification of mutations causing amino 
acid changes in consensu8 residues, first in hemophilia 
B patients defective in coagulation factor IX (Winship and 
Dragon, 1991), and more recently in Marfan syndrome 
patients defective in fibrillin-1 (Dietz et al., 1993; Hewett 
et al., 1993; Kainulainen et al., 1994). Moreover, the trans- 
membrane proteins Notch and Delta, product8 of the Dro- 
sophila neurogenic loci, have been shown to interact in 
vitro at the cell surface via their extracellular domains in 
a Ca2+-dependent manner (Fehon et al., 1990). Each of 
these proteins contains multiple extracellular EGF re- 
peats. Notch has 38 EGF-like domains and Delta has 9, of 
which at least 8 and 1, respectively, contain Ca2+-binding 
sequences. Notch and Delta appear to cooperate in medi- 
ating cell-ceil communication required for proper differen- 
tiation of neural lineage8 and are examples of an ever 
increasing family of proteins containing domains homolo- 
gous to EGF that play an important role in the control of 
different developmental processes. Homologs of Notch 
have been described in Caenorhabditis elegans (LIN-12; 
Yochem et al., 1988; Wilkinson et al., 1994), in humans 
(TAN-l ; Ellisen et al., 1991), and in Xenopus (Xotch; Coff- 
man et al., 1990). Another member of this family, crumbs, 
contains 30 EGF-like domains, of which at least seven 
are of the Ca2+-binding type, and plays a key role in the 
organization of epithelia in Drosophila (Tepass et al., 
1990). 
Extensive structural studies have been carried out on 
this type of EGF-like domain, principally ‘H nuclear mag- 
netic resonance (IH-NMR) investigations of the structure 
of the domain from clotting factors IX and X (Baron et al., 
1992; Selander et al., 1990; Selander-Sunnerhagen et al., 
1992). These showed that the overall fold of this domain 
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Table 1. Structure Determination and Refinement 
Processing Statistics 
Number of Maximum Total 
Data Set Crystals Resolution (A) Reflections 
Unique 
Reflections 
Percent 
Complete 
MFID 
w PM <F>/<E> 
Native 12 1.5 46451 13041 94.5 10.2 - 
Wt(CN), 1 2.6 12534 2177 94.3 5.4 16.0 (2.6 A) 0.61 
A, 
(2.6 A) 1.7 (2.6 A) 
Cocktail 1 3.5 4142 1196 97.6 5.6 11.2 (3.5 0.42 (3.5 A, 0.9 (3.5 k 
Refinement Statistics 
Resolution range 30-1.5A 
Number of reflections 13041 (negatives excluded) 
Rhnor 15.7% 
Number of protein atoms 590 
Number of other atoms 3 (Ca-) 206 (water molecules) 
Rms deviations from ideality Bond lengths: 0.010 A 
<B factor> backbone 15.6 k (Molecule I) 
Bond angles: 1.25O 
19.5 A2 (molecule II) 
B factor deviations, bond related 3.2 A2 (molecule I) 5.1 k (molecule II) 
R - = Z&/l,,, - (lr,)l/E,,C (Ih) in which h are unique reflection indices, I,,h are intensities of symmetry redundant reflections, and lh is the mean 
intensity. MFID is the mean fractional isomorphous difference. FM is the overall figure of merit: the cosine of the mean phase error of the phases. 
<F>/<E> is the phasing power: the rms value of Fn divided by the rms lack of closure error. 
RI, = Zhl IF& - IF,/, J/&lF&, where the sum is over the unique reflections, h. 
was similar to that observed in EGF itself, the main struc- 
tural feature being a two-stranded f3 sheet. Although these 
studies provided medium resolution information on protein 
conformation and indirect information on the ligands in- 
volved in binding CaH, they failed to identify structural 
features of this domain complexed with CaH that might 
explain its widespread distribution among extracellular 
proteins. 
We have now determined a high resolution X-ray crystal- 
lographic structure of the Ca2+-binding EGF-like domain 
from factor IX. This structure provides experimental evi- 
dence for a novel use of Ca2+ in stabilizing protein-protein 
interactions that is consistent with a general biological role 
for this domain. 
Results and Discussion 
The Structure: Flexibility and Strain 
We have determined the crystal structure of residues 46- 
64 of human clotting factor IX, which comprise the first 
EGF-like domain of the molecule, by the method of isomor- 
phous replacement. Although the crystals are well ordered 
and diffract X-rays to high resolution (1.5 A), the structure 
determination was hindered by the difficulty of obtaining 
useful heavy-atom derivatives and relied on the accurate 
measurement of anomalous differences by the use of syn- 
chrotron radiation, as described in the Experimental Pro- 
cedures. The present model has a crystallographic R fac- 
tor of 15.7% for all measurements between 30 and 1.5 
Figure 1. Stereoview of a Segment of the Electron Density Map (2F, - Fc) Calculated at 1.5 i Resolution and Contoured at 1.60 
The strand of polypeptide running from left to right across the top of the picture comprises residues 69-74, with the sequence YECWCP. 
Structure of a Caa-Binding EGF-like Domain 
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Figure 2. The Structure of the Ca”-Binding 
EGF-like Domain of Factor IX 
(A) Schematic diagram showing the overall 
structure, and relative arrangement in the ctys- 
tal, of the two independent Ca=-binding EGF- 
like domains that are present in the crystallo- 
graphic asymmetric unit (molecule I, yellow to 
red; molecule II, pale blue to green; Ca%, pur- 
ple).ThreeCa2+sitesareshown(twomajorand 
one minor site; see text for details), as are the 
Ca*+ ligands for each major site. 
(6) Stereo diagram showing the Ca traces of 
the two independent Ca2+-binding EGF-like do- 
mains(molecule I, red; molecule II, yellow). The 
structures have been superimposed by rigid- 
body operations. The rms deviation in Ca posi- 
tions is 0.4 A. The most significant differences 
occur between Glu-52 and Ser-53. where the 
deviations are 1.2 and 0.9 A, respectively. 
(C)Comparison of the three-dimensional struc- 
tures of EGF-like domains of factors IX and X, 
shown in stereo. (i) EGF-like domain of factor 
IX (molecules I and II, red and yellow, respec- 
tively; this study); (ii) Ca%-free NMR structure 
for the factor IX module, in cyan (Baron et al., 
1992); (iii) Ca=-free NMR structure for the cor- 
responding module from factor X, in green (Sel- 
ander et al., 1990); (iv) a C-terminal EGF-like 
domain from the crystallographic structure of 
factor X, in pink (Padmanabhan et al., 1993). 
Note that while the two molecules in our crys 
tals agree with an rms deviation of CR atoms 
of 0.4 A, the corresponding values for our struc- 
tures compared with th8 others are between 
1.4 and 1.5 A. 
a and excellent stereochemistry typified by a root mean chains. The overall structure of the domain is elongated 
square (rms) deviation from ideal bond lengths of 0.010 (Figure 2A), with dimensions 65 A x 15 A x 15 A. There 
a (Table l), and the electron density map is of high quality is little extended secondary structure, only a 6 hairpin (resi- 
(Figure 1). The unusual precision of this study allowed dues 61-65 and 66-76). However, there are six 6 turns, 
us to detect and model multiple conformations in 12 side two of them locked together. Of these turns, three are 
Figure 3. Sequence Alignments, Solvent Ac- 
cessibiiities, and B Factors 
The upper panel compares the sequences of 
human factor IX Ca*-binding EGF-likedomatn. 
the homoiogous domains from human factor 
X, human protein S (residues 153-200) Notch 
(residues 443-486) Delta (residues 52~SW), 
and human fibrfllin (residues 709-749). The 
coloring scheme for this part is as follows: 
Ca2* consensus residues are red. The areen 
blocked residues are conserved. The uppermost row indicates the Ca* iigands: an astertsk marks side-chain iigands; a pius marks ca&myi 
iigands; X marks the iigand contributed by the adjacent molecule. The second panel displays the relative solvent accesstbfiities (molecules I and 
Ii are sufficientiy similar that this picture is identical for both). The lower panel shows the mean 6 factors for the backbone atoms. 
60 
Figure 
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cule I is displayed u&g cbsed symbds, wfmreea rno&cuie II uses 
outline symbofs. Circlea and triangles qresent nongfycine and giy- 
tine reakfues, respectively. 
(B) Schematic diagram showing regions of strain in the two crystaiio- 
graphically independent domains. The glycine residues are colored 
type II (residues U-54,65-66, and 74-76) two are type 
I (residues 49-52 and 79-62), and one a type I’ (57-60). 
Since there are two independent copies of the polypeptide 
(I and II) in each asymmetric unit of the crystal, we can 
assess the flexibility of the structure. The two molecules 
are extremely similar (Figure 28; rms deviation in Ca posi- 
tions 0.4 A, in which we estimate the error in the coordi- 
nates to bs somewhat less than 0.2 A for the majority 
of the structure), indicating that the domain has a single 
well-defined structure in the presence of Ca2+. However, 
the individual B factors (which indicate the degree of flexi- 
bility within the crystal) for the two copies do not, overall, 
correlate well (correlation coefficient = 0.035; Acharya et 
al., 1991). Inspection of the variation in 6 factor as a func- 
tion of position in the molecule (Figure 3) shows that the 
local variations in flexibility are in fact rather similar be- 
tween the two molecules. However, the crystal contacts 
“pin-down” opposite ends of the two molecules so that 
there is an overall, and opposite, trend in the B factors 
within each molecule. This effect is not seen in larger glob- 
ular proteins and reflects the elongated, slightly flexible 
nature of this relatively small domain. 
The unusual nature of the structure of the domain is 
reflected in the amino acid composition, which is skewed 
compared with most globular proteins, with only eight hy- 
drophobic residues (the expected value would be 16 amino 
acids for a polypeptide of this length; McCaldon and Argo% 
1966). Thus, apart from the disulphide bonds that arevirtu- 
ally solvent inaccessible and one of the Caz+-binding con- 
sensus residues (Tyr-69) that is largely buried, the mole- 
cute has lit&r in the way of a hydrophobic core (Figure 
3). Although no residues lie in disallowed regions of the 
Ramachandran plot, almost one quarter lie in less favored 
regions (Fylure 4A). (This is more than expected for a 
weff-folded gtobular protein [Laskowski et al., 19931; how- 
ever, given the high resolution of the X-ray analysis, we 
are confident that it is not artifactual.) We believe that 
this may reffect the unusual structure of the domain, in 
particular, the lack of both regular secondary structure 
and a stabilizing hydrophobic core in this disulphide-rich 
domain. Evidence supporting the role of the disulphide 
bonds in maintaining a strained molecular conformation 
green, and residues whose backbone torsion angles are less favOred 
(as defined by PROCHECK; Laskowski et al., 1993) are coiored red. 
The disuiphide bonds are shown in yellow and the Ca% in purple. 
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Figure 5. Stereo Diagram of the Major Ca--Binding Site in Molecule I 
This site is essentially identical in both molecules I and II. Five side-chain oxygen ligands, in an approximately pentagonal arrangement, lie close 
to a common plane that includes the central Ca-. This view looks down on the pentagonal plane. The backbone atoms of molecule I are colored 
yellow, and those of molecule II are colored blue. The liganding side chains belong to residues Asp-64 (bidentate interaction), Asp-47, and Gln-50 
of molecule I and Asn-55 of molecule II. Two main-chain carbonyl oxygen atoms (from Asp-65 and Gly-45 of molecule I), complete the pentagonal 
bipyramidal coordination of Ca2+ (purple). 
is presented in Figure 48, where the residues with less 
favored backbone torsion angles are colored red. Note 
that the pattern of strain is very similar between the two 
molecules and lies entirely in loops between cysteine res- 
idues. 
Calcium Ligation 
Proton microprobe studies (Rao et al., 1995; E. Garman 
et al., unpublished data) indicated the Ca*+:protein stoichi- 
ometry to be 1.7 ( f 0.2):1. In agreement with this, the 
refined crystal structure contains three Ca% associated 
with a pair of domains, I and II (see Figure 2A). Two of 
these Ca& sites are well defined (Figure 5) and tightly 
formed, as judged by the crystallographic B factors that 
indicate that the Ca-s (B = 12 AT are as rigidly defined 
as the surrounding protein (B = 14 A2 for the Ca atoms 
of the surrounding residues). The third is less rigidly bound 
(B = 23 A’), with imperfect ligation. 
Of the ‘H-NW structures that have been reported for 
the Ca*-binding EGF-like domains from factor IX and the 
homologous protein factor X (Baron et al., 1992; Selander 
et al., 1990; Selander-Sunnerhagen et al., 1992) only one 
was determined in the presence of Ca*+ (Selander-Sun- 
nerhagen et al., 1992) and even in that study, the tech- 
nique was “blind” to the position of the Ca*+, which could 
only be inferred from the structure of the protein. The struc- 
tures determined by NMR are broadly similar to, although 
less precise than, our crystal structure. Thus, the rms devi- 
ation in Ca atoms between molecule I in our crystals and 
its Caa-free structure determined by NMR is 1.4A (Baron 
et al., 1992) while the corresponding value for the homolo- 
gous domain from factor X is 1.5 A (Selander et al., 1999). 
However, the Ca*+-free structures diverge from our Ca*+- 
bound structures in some regions, most significantly the 
N-terminal portion, which contributes the majority of the 
Ca% ligands (see below). Thus, if we consider only resi- 
dues up to and including 49, the corresponding rms devia- 
tions rise to 2.8 and 2.9 A, respectively, suggesting that 
Cd+ introduces a local conformational change in the N-ter- 
minal region (see Figure 2C). 
In spite of the limitations of the NMR experiments, the 
ligands suggested in one study (Selander-Sunnerhagen 
etal., 1992)areconfirmed byourcrystalstructure, in which 
they occur at the tight Ca’+-binding site, although we see, 
in total, seven liganding oxygen atoms compared with the 
five suggested from the NMR data. This major Ca*+- 
binding site is located between a two-stranded 8 sheet 
and the N-terminal loop in each of the two molecules. In 
both molecules, the details of the Ca- ligation are essen- 
tially identical: the seven ligands form a pentagonal bipyra- 
mid (Figure 5) with an average Ca%-0 distance of 2.3 A. 
This coordination geometry is typical of that observed in 
many Ca2+-regulated proteins (for review see Strynadka 
and James, 1989). 
If we consider the Ca*+ most closely associated with 
molecule I, six of the ligands come from that molecule, 
four are supplied by carboxylatelcarboxyamide side 
chains (atoms ODl and OD2 of Asp-84, OEl of Gln-50, 
and ODl of Asp-47), and two are supplied by main-chain 
carbonyl oxygen atoms (Gly-48 and Asp-85). The seventh 
ligand is atom ODl of Asn-58 belonging to molecule II 
(Figure 5). Interestingly, only three out of the five consen- 
sus residues (Asp-47, Asp-49, Gln-50, Asp-84, and Tyr-89 
in human factor IX; see Figure 3, top) (Rees et al., 1988; 
Figure 6. Observed and Modefed Protein-Protein Interactions of the Ca*-Binding EGF-like Domain 
(A) Stereoview of the CaQtabilized helices of EGF-like domains observed in the crystal. The polypeptide backbone is shown. Small spheres 
mark the N- and C-termini of each domain, and larger spheres mark the major Ca?*-binding sites. Note that the N- and C-termini of consecutive 
domains approach within 3.7 A. The packing of helices (colored red, blue, and green) of domains, as observed in the crystal is shown. Note the 
snug packing of these helices in an antiparallel array. Parallel packing can be achieved almost as economically (data not shown). 
(B) Modeling of the interaction between the Gla domain and EGF-like domain of human factor IX (residues l-34). The coordinates from the 
homologous Gla domain of prothrombin were used to model residues l-45 of the factor IX Gla domain (Gla domain shown in yellow, whereas 
the EGNike domain is color ramped, blue to green, between N and C domain termini). The Gla-00 residue is shown. The polypeptide backbone 
has not be?r~ altered from that observed in the respective crystal structures, and yet residues Tyr-45 (top left) and Val-46 (top right) approach to 
within -3 A. The hydrophobic restdues immediately preceding residue 45 and the CaZf site immediately following residue 46 (Ca- shown in 
purple) confer stringent structural restrictions on this modeling. There are extensive stabilizing interactions between the two domains as modeled. 
Handford et al., 1991; Mayhew et al., 1992) interact directly 
with the Ca=. One of the others, Tyr-69, has an important 
structural role (as noted above, it has strong hydrophobic 
interactions, in particular with Pro-55), in agreement with 
earlier mutagenic studies (Hughes et al., 1993) which 
showed that a TyrVal substitution at residue 69 caused 
a reduction in the yield of correctly disulphide-bonded ma- 
terial when the isolated EGF domain was refolded in vitro. 
These studies also demonstrated that Tyr-69 was essen- 
tial for clotting activity of recombinant factor IX. The final 
consensus residue, Asp-49, which had been proposed to 
be a direct ligand (Handford et al., 1991), in fact plays an 
indirect role: the carboxylate side chain of this residue 
forms a crucial hydrogen bond with the main-chain amide 
nitrogen of Cys-51, forming an ASX turn, a structure pre- 
viously observed in another high affinity Ca2+-binding site 
(Stuart et al., 1979; Rees et al., 1993). Mutagenic studies 
support such a structural role for this residue; an aspara- 
gine substitution, which can still form the crucial hydrogen 
bond and, hence, maintain the conformation of the Ca%- 
binding loop, has only a minor effect on Ca* binding 
(Mayhew et al., 1992). 
The minor Ca*+-binding site is located on the surface of 
the N-terminal loop of molecule I (see Figure 2A). The 
Ca% occupying this site is coordinated by eight ligands, 
comprising six water molecules, the main-chain carbonyl 
oxygen, and the side-chain hydroxyl of Ser-53. It is uncer- 
tain whether this site is of physiological significance, since 
in human factor IX Ser-53 is posttranslationally modified 
with carbohydrate (Hase et al., 1988; Nishimura et al., 
1989). Furthermore, this Ca2+ site is not occupied in mole- 
cule II. 
Bole of Repeated Caz+-Binding Domains 
The most likely explanation for the recurrence of the multi- 
ple Ca2+-binding EGF-like domains within proteins is that 
they are involved in Ca2+-mediated protein-protein inter- 
actions, either with other such domains or with different 
structural motifs. While our crystal structure is only of a 
single domain, there is now considerable evidence that 
the essential features of such protein-protein interactions 
may, on occasion, be recapitulated in the crystalline state 
owing to the adhesive interactions that forge the crystal 
lattice. An early example of this was the homophilic inter- 
actions between molecules of the cell adhesion immuno- 
globulin superfamily molecule CD2 (Jones et al., 1992) 
$;cture of a Ca2+-Binding EGF-like Domain 
that reveal the essential features of the general mode of 
adhesive interactions between immunoglobulin domains 
(demonstrated by further structural studies [Bodian et al., 
1994) and mutagenesis results [van der Merwe et al., 
19953). Very recently, the structure of an integrin I domain 
(Lee et al., 1995) provides an example even more closely 
analogous to the present work, in which a metal ion is 
shared between two molecules, providing a compelling 
illustration of the long-standing hypothesis for the role of 
metal in mediating integrin-ligand interactions. 
Our crystals appear to be particularly illuminating in this 
respect, allowing us to make a number of predictions re- 
garding the biological function of this domain in a variety 
of proteins. Perhaps the clearest examples of this are for 
proteins that contain many Ca*-binding EGF-like repeats 
in tandem, often with extremely short linkers between 
them. Fibrillin-1 , a major structural component of a subset 
of connective tissue microfibrils, is such a protein. It con- 
tains 43 of these domains arranged in 9 segments, one 
of which includes 12 contiguous EGF-like domains (Per- 
eira et al., 1993; Corson et al., 1993). Evidence from pa- 
tient studies demonstrates that defective CaB binding to 
a single EGF-like domain within fibrillin-1 can lead to the 
clinical condition known as the Mar-fan syndrome (Dietz 
et al., 1993; Hewett et al., 1993). The elongated ultrastruc- 
tural appearance of the molecule (Sakai et al., 1991) sug- 
gests that there is a repeated mode of interaction between 
adjacent EGF-like domains. Given these known con- 
straints, it is of interest that the crystals we have analyzed 
are built from tightly wound helices of domains, with a 
Ca*+ stabilizing and defining the geometry of the domain- 
domain interface (Figure 6A). These experimentally ob- 
served Ca2+-stabilized 63 helices, with a pitch of 33 A and 
a diameter of 40 A, provide us with a model for the interac- 
tion of these domains in fibrillin that is compatible with our 
current knowledge of the microfibril structure (Sakai et al., 
1991) and that also would explain how the loss of a single 
Ca2+-binding site could destabilize the microfibril, leading 
to the Marfan syndrome. Although the stacks observed in 
the crystals clearly represent a stable assembly for such 
domains, since they are not linked in a single covalent 
chain, there is no a priori reason to expect the adjacent 
units to present their chain termini in proximity, as would 
be required for molecules such as fibrillin-1 in which there 
are often very short linkers between adjacent domains. In 
fact, the termini are a mere 4 A apart (Figure 6A). The de 
facto satisfaction of such a stringent unseen constraint 
adds considerable weight to the argument that the struc- 
tures we observe are avalid model for proteins with multi- 
ple Ca2+-binding EGF-like repeats. 
The higher order association of such helices, either par- 
allel or antiparallel, would allow extensive protein-protein 
interactions between two such molecules (once again the 
packing of the helices in the crystal provides a very plausi- 
ble starting model for such associations; Figure 6A). Ho- 
motypic interactions of this type would provide a mecha- 
nism for the association of fibrillin monomers within a 
microfibril (Sakai et al., 1991). Heterotypic interactions of 
this type could be responsible for the Ca2’dependent as- 
sociation demonstrated by Notch and Delta and would 
provide an explanation for the ability of Notch to act as a 
multifunctional receptor for other developmentally im- 
portant proteins with EGF-like domains such as Serrate 
(Rebay et al., 1991). Deletion analyses have localized the 
region of Notch that binds Delta to EGF-like repeats 11 
and 12, both of which are predicted to be Ca2+-binding 
domains (Rebay et al., 1991). Significantly, it is a pair of 
domains that acts as the minimum functional unit, and 
neither EGF-like repeat 11 nor 12 alone supports binding. 
This result is consistent with our structural data that show 
that protein-protein interactions between EGF-like do- 
mains in the crystal. are Caz+ dependent, and therefore, 
domains are unlikely to function independently of one an- 
other. We predict that mutations that change Ca%-binding 
residues in either domains 11 or 12 of Notch would abolish 
the Notch-Delta interaction, since this would lead to a 
destabilization of the proposed helical structure formed 
from sequential Caw-binding EGF-like domains. Although 
our model forthe heterotypic associationof Ca2+-stabilized 
helices provides an explanation for the interaction of Notch 
with Delta and other related proteins, the identification of 
structural features that determine the specificity of such 
interactions remains a challenging area of research. 
Our model for the association of EGF-like domains 
would also explain some of the properties of protein S, an 
important regulator of coagulation, which has four consec- 
utive EGF-like domains of the Ca%-binding type. It is inter- 
esting to note that the Car+ binding affinity exhibited by 
this protein is at least an order of magnitude greater than 
that in factors IX, X, and the homologous protein C (Dahl- 
back et al., 1990). Since the linking region between the 
four domains is very short, our crystal packing provides 
a natural model for protein S in which the donation of a 
Ca* ligand from an adjacent EGF-like domain stabilizes 
the domain interface, facilitating Ca% binding to the next 
domain. Inspection of the known amino acid sequences 
of EGF-like domains from each of the above mentioned 
proteins (a synoptic compilation of sequence aligments is 
presented in Figure 3) shows that a residue equivalent to 
Asn-66 is present that could donate an oxygen ligand to 
complete the Ca2+ coordination in the adjacent domain, 
although in some cases, variations in loop length render 
the assignment ambiguous. 
Role in Clr and Cls 
Like factors IX and X, the homologous complement serine 
proteases Cl r and Cl s each contain a single Ca2+-binding 
EGF-like domain (for review see Arlaud et al., 1969; Day 
et al., 1993). These proteins mediate heterologous and 
homologous Ca*dependent interactions involved, re- 
spectively, in the formationof theCls-Clr-Cl r-Cls tetra- 
mer(partof the first component Cl of theclassical pathway 
of complement) and the Cls-Cls homodimer. Studies on 
the Ca”-binding properties of proteolytic fragments de- 
rived from these proteins, in particular those derived from 
Cls, support an important role for the single Ca2+-binding 
EGFdomain in stabilizing protein-protein interactions. a2, 
a proteolytic fragment derived from plasmin treatment of 
Cls, which contained the Ca2+-binding EGF-like domain, 
failed to exhibit native binding of Ca* and to bind to Cl r 
Cell 
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Table 2. Predicted Effects of Mutations in the CaB-Binding EGF-like Domain of Human Factor IX 
Mutation Patients 
Isolated Intact 
Domain Factor IX Predicted Effect 
47D-+G 
47D*E 
47D-+K 
47D*N 
46G-R 
46G*V 
49D*E 
49D+N 
5-E 
50Q-P 
51c-w 
55P*A 
55P+S 
55P-L 
55P-Q 
56C+R 
56C+S 
56C+Y 
59G-G 
59G+V 
6OG+S 
6oG-R 
60G+D 
62C+Y 
64D-N 
64D+G 
64D+E 
640-K 
64D+V 
661-T 
69Y-C 
69Y+V 
69Y+F 
71c+s 
72WAR 
73c-Y 
76G-V 
77F-C 
76E+D 
76E+K 
Y Y 
Y Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
I; 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y I 
Y I 
Y 
Y 
Loss of Ca” ligand 
? 
? 
Loss of stabilizing H bond 
Retains H bond 
Retains Ca% ligand 
Loss of Ca% ligand 
Lose of C51-C62 S-S bond 
Loss of P55-Y69 hydrophobic interaction 
Loss of C56-C71 S-S bond 
G required for left-handed turn 
No room for larger side chain 
Loss of C62-C51 S-S bond 
Loss of Caa ligand unless compensatory 
change at Q50 (Q+E) 
Loss of Ca*+ ligand 
? 
Loss of Y69-P55 hydrophobic interaction 
Retains hydrophobic interaction 
Loss of C56-C71 S-S bond 
Loss of hydrophobic stacking 
Loss of C73-C62 S-S bond 
G required for left handed turn 
lnvoved in hydrophobic interactions 
? 
7 
A Y in the appropriate column indicates that the mutation was studied in patients (from Giannelli et al., 1994 with a few omissions), or in isolated 
domains (Handford et al., 1991; Mayhew et al., 1992; Hughes et al., 1993) or in protein-engineered intact factor IX (Rees et al., 1966; Hughes 
et al., 1993). A question mark indicates an unknown effect of the mutation on structure. 
in the presence of Ca*+ and was unable to dimerize (Thie- 
lens et al., 1990a). However, a fragment (Cl sa) containing 
both the EGF-like domain and the adjacent N-terminal do- 
main of Cls bound Ca2+ with almost native affinity and 
formed homodimers and Ca=dependent tetramers with 
native Cl r (Thielens et al., 199Ob). These data are consis- 
tent with the N-terminal domain providing a ligand to com- 
plete the coordination sphere of Ca- bound to the EGF- 
like domain. However, it should be noted that structural 
features in addition to Ca*+ binding to the EGF-like domain 
are likely to be involved in mediating the dimerization of 
Cls, since a homologous Clr fragment (Clra) does not 
form homodimers (Thielens et al., 1990b). 
Role in Factors IX and X 
Factor IX does not possess tandem Ca*-binding EGF-like 
domains. However, Ca* binding to the isolated EGF-like 
domains from factors IX and X is 29 to 40-fold reduced 
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compared with the high affinity binding exhibited by the 
native protein (Handford et al., 1991; Persson et al., 1989) 
suggesting a role for Ca*+ in modulating protein-protein 
interactions. In both factors IX and X, a ycarboxyglutamyl 
(Gla) domain is N-terminal to the EGF-like domain, linked 
to it by a short hydrophobic region (Stenflo, 1991). In factor 
X, high affinity Ca* binding is restored if a fragment con- 
taining residues 29-45 of the Gla-hydrophobic domain 
is attached to the isolated Ca*+-binding EGF-like domain 
(Valcarce et al., 1993). As observed above in our crystals, 
the seventh Ca2+ ligand is also donated N-terminal with 
respect to the Ca2+-binding site in the adjacent EGF-like 
domain, suggesting that a Ca* ligand substituting for Asn- 
58 may be provided by a residue in this sequence. Fortu- 
nately, coordinates for the homologous Gla domain of pro- 
thrombin fragment 1 are available (Soriano-Garcia et al., 
1992) and given the structural overlap between this mo- 
lecular fragment and ours (the prothrombin fragment 1 
structure extends beyond the Gladomain, providing linker 
residues; see legend to Figure 8B), there are avery limited 
range of possible orientations between these domains that 
will present a seventh ligand to the Ca% bound to the 
EGF-like domain. Modeling, treating the observed struc- 
tures as rigid bodies, is therefore relatively straightforward 
and unambiguous (Figure 68) and suggests that one or 
other of the carboxylate groups of Gla-40 is the most likely 
candidate. Recent ‘H-NMR structural determination of the 
homologous Gla-EGF domain protein fragment from bo- 
vine factor X, performed in the presence of limiting [Caz+] 
such that only the high affinity site within the EGF domain 
is saturated, shows that the Gla domain folds over the 
EGF domain in the region of the Ca2+-binding site and 
thus lends experimental support to our modeling studies 
(Selander-Sunnerhagen, 1994). Currently, no Glad0 mu- 
tants of factor IX have been identified in hemophilia B 
patients (Giannelli et al., 1994), although our prediction 
of Ca2+ binding to residue 40 could be tested experimen- 
tally by comparing Ca2+ binding of wild-type and mutant 
factor IX protein fragments encompassing residues 29- 
84. Mutations at position 40 should significantly reduce 
high affinity Ca% binding. On the basis of the crystallo- 
graphic structure, ie can predict accurately the effect not 
only of naturally occurring mutations, as observed in he- 
mophilia B patients with defective factor IX and in Marfan 
syndrome patients defective in the connective tissue pro- 
tein fibrillin, but also synthetic mutations. Predictions for 
the Ca2+-binding EGF-like domain of factor IX are detailed 
in Table 2. While most mutations are explicable by refer- 
ence to the local structure of the domain, a few are not 
(e.g., substitutions at Gly-48,118-66, and Glu-78). It is possi- 
ble that these produce an effect by interfering with normal 
protein-protein contacts either within factor IX or with 
other components of the clotting cascade, such as factors 
Villa or X. 
Conclusions 
In summary, the crystal structure of a Ca2+-binding EGF- 
like domain from factor IX has defined the seven ligands 
in a novel type of extracellular Ca2+-binding site and has 
fully explained the structural significance of the Ca2+- 
binding consensus sequence associated with this domain. 
The helical arrangement of the domains in the crystal has 
allowed us to propose a general mechanism, consistent 
with known functional data, by which Ca* bound to EGF- 
like domains can stabilize protein structure and direct pro- 
tein-protein interactions. This novel mechanism accounts 
for the presence and biological importance of this type of 
domain in functionally unrelated extracellular proteins. 
Exprlmental Procedures 
Clystalllxatlon and Data Collectlon 
The EGF-likedomain, residues4664of human factor IX, was purified 
and crystallized as described elsewhere (Mayhew et al., 1992; Rao 
et al., 1995). Crystals (largest size, 1.0 x 0.5 x 0.3 mm3 belong to 
the tetragonal spa? group P4&!,2, with unit cell dimensions a = b = 
40.3 A, c = 96.2 A. There are two molecules in the asymmetric unit. 
The crystals diffract beyond 1.5 A and are relatively stable in the X-ray 
beam. 
Structure Determlnatlon 
Heavy-Atom Derivatives 
The crystals were stabilized in 0.1 M Tris-HCI buffer with 55% PEG 
400 (pH 7.3) incubated at room temperature for 4-72 hr with different 
heavy-atom reagents. 
Data Collection 
Data sets were collected in-house on a Seimens multiwire area detec- 
tor or Marresearch imaging plate detector. Synchrotron data were col- 
lected at the SRS Daresbury stations 9.5 and 9.6 and at CHESS station 
Fl. Initial data processing used programs MOSFILM (A. Leslie, per- 
sonal communication), XDS (Kabsch, 1966) and DENZO(Ctwinowski, 
1993) and further processing used in-house programs (Stuart et al., 
1979). A set of native data was created from a number of data sets 
to Bragg spacing of 2.0 A for initiql phasing and refinement. Further 
native data was coll~ed to 1.5 A at station 9.6 at Daresbury and 
merged with the 2.0 A data for final refinement. Over 90 derivatives 
were screened; the w(CN), derivative was substituted at a single 
site, lying almost exactly on a crystallographic 2-fold axis (0.11, 0.09, 
0.00). To improve the anomalous scattering data for this derivative, 
data were collected (on a Marresearch imaging plate detector) using 
radiation of wavelength 0.692 A at station 9.5 at Daresbury. An addi- 
tional minor derivative was obtained by soaking a crystal in a cocktail of 
nine different heavy-atom reagents; a single heavy atom, of unknown 
chemistry, became loosely associated with the protein (also very close 
to a special position; coordinates 0.21, 0.51, 0.05). Difference Pat- 
terson maps were interpreted using GROPAT (Jones et al., 1991). 
Heavy-atom parameter refinement and phase determination for the 
two derivatives were performed using MLPHARE (in the CCP4 pro- 
gram suite; Collaborative Computational Project, 1994) and electron 
information from the K#t(CN)r derivative played a crucial role in the 
phasing. The quality of the electron density was sufficient to determine 
reliable residue positions throughout, and an initial model was built 
based on the NMR structure (Baron et al., 1992) using the program 
FRODC (Jones, 1965). 
Refinement 
Initial refinement was. by simulated annealing with XPLOR 3.1 
(Briinger, 1992) at 2.0 A with tightly restrained chemistry and no local 
symmetry restraints after the second cycle of refinement. Further re- 
finement to 1.5 A was carried out by positional and temperature factor 
refinement using XPLOR, using the stereochemical parameters of 
Engh and Huber (1991). During the course of the refinement, water 
sites were gradually added and the stereochemical restraints modified, 
so that, eventually, electrostatic and van der Waals terms were omitted 
from the target function. For 12 residues (molecule I, Lys-63, Asp-65, 
Glu-70, Glu-76; molecule II, Glu-52, Lys-63, Asp-65, Glu-70, Trp-72, 
Phe-75, Glu-76, Glu-63). alternative sidechain conformations were 
built and several partially occupied water sites were added. In total, 
the model includes 206 water moleules (including 116 that have been 
assigned an occupancy of 0.5). The final crystallographic R factor of 
Cdl 
146 
15.7% is for all measurements between 36 and 1.5 A Bragg spacings 
with a bulk solvent correction (as implemented within XPLOR; Briinger, 
1992). The R factor for the 1.6-l 5 A shell of data is 28.2%. 
Flgurw 
Figures 1 and 6A were produced using FRODO (Jones, 1965). Figures 
2, 46, 5, and 68 were produced using a version of MOLSCRIPT 
(Kraulis, 1991) modified by R. Esnouf and rendered with RASTERID 
(Merritt and Murphy, 1994). In Figure 3, sequence alignments were 
produced using ALSCRIPT (Barton, 1993). and solvent accessibilities 
were calculated using the program DSSP (Kabsch and Sander, 1963) 
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